Jones Financial Companies
IMCR icon

Jones Financial Companies’s Immunocore IMCR Stock Holding History

Jones Financial Companies’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-78
Closed -$2.31K – 4099
2025
Q1 		$2.31K Hold
78
– – ﹤0.01% 3213
2024
Q4 		$2.3K Buy
+78
New +$2.47K ﹤0.01% 2964

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Jones Financial Companies's IMCR Position: Q2 2025 in Review

Jones Financial Companies sold out of Immunocore (IMCR) in Q2 2025, closing a stake of 78 shares — an estimated $2.31K sold.

Jones Financial Companies first reported a position in IMCR in Q4 2024 and held it in 2 quarters. The position peaked at $2.31K in Q1 2025. 133 funds tracked by Wall St. Rank hold IMCR as of Q2 2025.

  • Jones Financial Companies reported no remaining Immunocore position as of Q2 2025 after selling out during the quarter.
  • Jones Financial Companies sold 78 Immunocore shares in Q2 2025, an estimated $2.31K.
  • Jones Financial Companies first reported a position in Immunocore in Q4 2024 and held it in 2 quarters.
  • Jones Financial Companies's Immunocore position peaked at $2.31K in Q1 2025.
  • 133 funds tracked by Wall St. Rank held Immunocore as of Q2 2025.

Based on Jones Financial Companies's 13F filing for Q2 2025, filed 13 Aug 2025.